First case report of catheter-related fungemia by Candida nivariensis in the Iberian Peninsula;Primer caso de fungemia asociada a catéter por Candida nivariensis en la Península Ibérica

Revista Iberoamericana de Micologia

Volumn 30, Issue 1, 2013, Pages 69-71

  López Soria, Leyre M ^a   Bereciartua, Elena ^a   Santamaría, Marta ^a   Soria, Luis Miguel ^a   Hernández Almaraz, José Luis ^a   Mularoni, Alessandra ^a   Nieto, Javier ^a   Montejo, Miguel ^a  

^a HOSPITAL DE CRUCES   (Spain)

Author keywords

Candida nivariensis; Candidemia; Caspofungin; Catheter; Fluconazole; Fungemia

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; CASPOFUNGIN; FLUCONAZOLE; FUNGAL DNA; FUNGAL RNA; INTERNAL TRANSCRIBED SPACER; ITRACONAZOLE; MICAFUNGIN; POSACONAZOLE; RIBOSOME RNA; VORICONAZOLE;

AGED; ARTICLE; BLOOD CULTURE; CANDIDA; CANDIDA NIVARIENSIS; CANDIDEMIA; CASE REPORT; CATHETER INFECTION; CENTRAL VENOUS CATHETER; COLONY FORMATION; CULTURE MEDIUM; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA SEQUENCE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FUNGUS CULTURE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HOSPITALIZATION; HUMAN; INTESTINE FISTULA; INTESTINE SURGERY; MALE; MALNUTRITION; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RELAPSE; SPAIN; TREATMENT DURATION;

AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CANDIDA; CANDIDEMIA; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; COLONIC DISEASES; DRUG RESISTANCE, MULTIPLE, FUNGAL; ECHINOCANDINS; HUMANS; IMMUNOCOMPROMISED HOST; INTESTINAL FISTULA; JEJUNAL DISEASES; MALE; MALNUTRITION; MYCOLOGICAL TYPING TECHNIQUES; MYCOLOGY; PARENTERAL NUTRITION; SPAIN; SPECIES SPECIFICITY;

CANDIDA; CANDIDA GLABRATA; FISTULA;

EID: 84872792481     PISSN: 11301406     EISSN: 21739188     Source Type: Journal    
DOI: 10.1016/j.riam.2012.09.001     Document Type: Article

References (11)

1. Alcoba-Flórez J., Méndez-Alvarez S., Cano J., Guarro J., Pérez-Roth E., del Pilar Arévalo M. Phenotypic and molecular characterization of Candida nivariensis sp.nov., a possible new opportunistic fungus. J Clin Microbiol 2005, 43:4107-4111.
2. Borman A.M., Petch R., Linton C.J., Palmer M.D., Bridge P.D., Johnson E.M. Candida nivariensis, an emerging pathogenic fungus with multidrug resistance to antifungal agents. J Clin Microbiol 2008, 46:933-938.
3. Cervera C. Candidemia y candidiasis invasora en el adulto: formas clínicas y tratamiento. Enferm Infecc Microbiol Clin 2012, 30:483-491.
4. Chowdhary A., Randhawa H.S., Khan Z.U., Ahmad S., Juneja S., Sharma B., et al. First isolations in India of Candida nivariensis, a globally emerging opportunistic pathogen. Med Mycol 2010, 48:416-420.
5. Correia A., Sampaio P., James S., Pais C. Candida bracarensis sp. nov., a novel anamorphic yeast species phenotypically similar to Candida glabrata. Int J Syst Evol Microbiol 2006, 56:313-317.
6. Cuenca-Estrella M., Gómez-López A., Isla G., Rodríguez D., Almirante B., Pahissa A., et al. Prevalence of Candida bracarensis and Candida nivariensis in a Spanish collection of yeasts: comparison of results from a reference centre and from a population-based surveillance study of candidemia. Med Mycol 2011, 49:525-529. The Barcelona Candidemia Project Study Group.
7. Fujita S., Senda Y., Okusi T., Ota Y., Takada H., Yamada K., et al. Catheter-related fungemia due to fluconazole-resistant Candida nivariensis. J Clin Microbiol 2007, 45:3459-3461.
8. Horn D.L., Neofytos D., Anaissie E.J., Fishman J.A., Steinbach W.J., Olyaei A.J., et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 2009, 48:1695-1703.
9. Lockhart S.R., Messer S.A., Gherna M., Bishop J.A., Merz W.G., Pfaller M.A., et al. Identification of Candida nivariensis and Candida bracarensis in a large global collection of Candida glabrata isolates: comparison to the literature. J Clin Microbiol 2009, 47:1216-1217.
10. Miranda-Zapico I., Eraso E., Hernández-Almaraz J.L., López-Soria L.M., Carrillo-Muñoz A.J., Hernández-Molina J.M., et al. Prevalence and antifungal susceptibility patterns of new cryptic species inside the species-complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital. J Antimicrob Chemother 2011, 66:2315-2322.
11. Pemán J., Cantón E., Quindós G., Eraso E., Alcoba J., Guinea J., et al. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey. J Antimicrob Chemother 2012, 67:1181-1187. FUNGEMYCA Study Group.